Fennec Pharmaceuticals Inc. (FENC) NASDAQ

9.02

+0.02(+0.22%)

Updated at September 08 04:00PM

Currency In USD

Valuation

Market Cap172.5M
Enterprise Value165.2M
P/E Ratio-20.73
PEG Ratio-1.35
Price/Sales Ratio7.44
Price/Book Ratio-33.44
Enterprise/Revenue7.46
Enterprise/EBITDA-27.89

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.36
Operating Margin-0.29

Management Effectiveness

Return On Assets-0.27
Return On Equity2

Income Statement

Revenue47.54M
Revenue/Share1.2
Gross Profit44.35M
EBITDA3.6M
Net Income-436,000
Diluted EPS-0.02

Balance Sheet

Total Cash18.7M
Total Cash/Share0.68
Total Debt19.36M
Total Debt/Equity-2.59
Current Ratio4.85
Book Value Per Share-0.27

Price History

52-Week Change71.81
52-Week High9.42
52-Week Low3.96
Moving Average 50 Days8.57
Moving Average 200 Days6.96

Statistics

Average Volume65,677
Shares Outstanding27.48M
% Held by Institutions48.11

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:3
Last Split DateSeptember 09, 2014